[go: up one dir, main page]

NO911047L - Labdaner og fremgangsmaate for deres fremstilling. - Google Patents

Labdaner og fremgangsmaate for deres fremstilling.

Info

Publication number
NO911047L
NO911047L NO91911047A NO911047A NO911047L NO 911047 L NO911047 L NO 911047L NO 91911047 A NO91911047 A NO 91911047A NO 911047 A NO911047 A NO 911047A NO 911047 L NO911047 L NO 911047L
Authority
NO
Norway
Prior art keywords
labdans
procedures
preparation
Prior art date
Application number
NO91911047A
Other languages
English (en)
Other versions
NO911047D0 (no
Inventor
Yatendra Khandelwal
Rajeshwari Kannan
Bansi Lal
Ramanujam Rajagopalan
Vijay Atmaram Aroskar
Alihussein Nomanbha Dohadwalla
Richard Helmut Rupp
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO911047D0 publication Critical patent/NO911047D0/no
Publication of NO911047L publication Critical patent/NO911047L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO91911047A 1990-03-17 1991-03-15 Labdaner og fremgangsmaate for deres fremstilling. NO911047L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90105072 1990-03-17

Publications (2)

Publication Number Publication Date
NO911047D0 NO911047D0 (no) 1991-03-15
NO911047L true NO911047L (no) 1991-09-18

Family

ID=8203766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911047A NO911047L (no) 1990-03-17 1991-03-15 Labdaner og fremgangsmaate for deres fremstilling.

Country Status (11)

Country Link
US (1) US5206241A (no)
EP (1) EP0447962A1 (no)
JP (1) JPH04330070A (no)
KR (1) KR920005719A (no)
AU (1) AU7294491A (no)
CA (1) CA2038405A1 (no)
IE (1) IE910889A1 (no)
NO (1) NO911047L (no)
NZ (1) NZ237442A (no)
PT (1) PT97045A (no)
ZA (1) ZA911927B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI913506A (fi) * 1990-07-24 1992-01-25 Hoechst Ag Foerfarande foer framstaellning av 6-(substituerat aminopropionyl)-derivat av forskolin.
KR920002574A (ko) * 1990-07-24 1992-02-28 이젠브루크, 라피체 6-(3-치환된 아미노프로피오닐)-7-데아세틸포르스콜린 유도체의 제조방법
ES2065843B1 (es) * 1993-03-10 1996-02-16 Univ Granada Aplicacion de ent-11 , 16-dihidroxi-18-nor-4a -carboximetil-oxido de manoilo como inhibidor de la adenilatociclasa.
ES2065844B1 (es) * 1993-03-10 1996-02-16 Univ Granada Aplicacion de ent-16,18-dihidroxi-6-oxo-oxido de manoilo como inhibidor de la adenilatociclasa.
ES2065842B1 (es) * 1993-03-10 1996-02-16 Univ Granada Aplicacion de ent-3b,6b,12b-trihidroxi-13-epi-oxido de manoilo como activador de la adenilatociclasa
US5458883A (en) * 1994-01-12 1995-10-17 Duke University Method of treating disorders of the eye
CA2417552C (en) * 2000-06-27 2014-05-13 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557784C2 (de) * 1975-12-22 1986-04-17 Hoechst Ag, 6230 Frankfurt Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate
SE395991B (sv) * 1975-12-17 1977-08-29 Asea Ab Rotor for turbogenerator
DE2640275A1 (de) * 1976-09-08 1978-03-09 Hoechst Ag Pharmakologisch wirksame substanz aus labiaten
US4517200A (en) * 1982-12-27 1985-05-14 Schering-Plough Corporation Method for treating allergic reactions with forskolin
ATE62683T1 (de) * 1985-03-01 1991-05-15 Hoechst Roussel Pharma Labdanderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
IN163242B (no) * 1985-05-03 1988-08-27 Hoechst India
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
DE3623300A1 (de) * 1986-07-11 1988-01-21 Hoechst Ag 7-acyloxy-6-aminoacyloxypolyoxylabdane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IN166900B (no) * 1987-06-03 1990-08-04 Hoechst India
ES2061564T3 (es) * 1987-06-29 1994-12-16 Nippon Kayaku Kk Nuevo procedimiento para la preparacion de derivados de 6,7-diacil-7-desacetilforscolina.
IN168181B (no) * 1987-12-01 1991-02-16 Hoechst India
FR2650953B1 (fr) * 1989-08-17 1991-12-06 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant au moins un derive de labdane, ou un extrait de plante en contenant; composition cosmetique ou pharmaceutique, notamment dermatologique l'incorporant

Also Published As

Publication number Publication date
ZA911927B (en) 1991-12-24
JPH04330070A (ja) 1992-11-18
KR920005719A (ko) 1992-04-03
PT97045A (pt) 1991-10-31
NO911047D0 (no) 1991-03-15
AU7294491A (en) 1991-09-19
NZ237442A (en) 1993-05-26
CA2038405A1 (en) 1991-09-18
IE910889A1 (en) 1991-09-25
US5206241A (en) 1993-04-27
EP0447962A1 (en) 1991-09-25

Similar Documents

Publication Publication Date Title
NO893678L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO881660D0 (no) Hepariner og femgangsmaate for deres fremstilling.
NO900577L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO912058L (no) Bioforlikelige membraner, deres fremstilling og anvendelse
NO912960D0 (no) Polylaktider, deres fremstilling og anvendelse.
NO922275D0 (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
NO904551D0 (no) Quinolonforbindelser og fremgangsmaate for deres fremstilling.
NO910003L (no) Vitamin e-derivater og fremgangsmaate for deres fremstilling.
NO875358D0 (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
NO915105L (no) Organiske kopolymerer, fremgangsmaate for deres fremstilling og anvendelse
NO903636L (no) Makrocykliske forbindelser og fremgangsmaate for deres fremstilling.
NO894624D0 (no) Kopolymerer og fremgangsmaate for deres fremstilling.
NO895030L (no) 2-imino-benzotiazolinderivater og deres fremstilling.
NO903096D0 (no) Termotrope semialifatiske kopolyesteramider og deres fremstilling.
NO903169L (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
NO904552D0 (no) Quinolonforbindelser og fremgangsmaate for deres fremstilling.
NO911047L (no) Labdaner og fremgangsmaate for deres fremstilling.
NO883114D0 (no) 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling.
NO900252D0 (no) Cefasporinderivater og fremgangsmaate for fremstilling derav.
NO893565D0 (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO894697L (no) Penemderivater og fremgangsmaater for deres fremstilling.
NO873126D0 (no) Cefalosporiner og derivater derav og fremgangsmaater for deres fremstilling.
NO901052D0 (no) 1h-pyrazol-1-acetamider og fremstilling derav.
NO912526L (no) Cefalosporinderivater og fremgangsmaate for deres fremstilling.